Skip to playerSkip to main content
  • 5 days ago
US stock futures are trading higher this Friday morning as investors react to developments across Big Tech, semiconductors, biotech, and micro-cap stocks.

Here are the stocks investors are watching today:

Apple
Reportedly scaled back production and promotion of its Vision Pro headset following sluggish sales, highlighting challenges in turning the mixed-reality device into a mass-market product.
Shares slipped 0.5% to $271.86.

Taiwan Semiconductor Manufacturing
Secured a one-year US export license allowing the company to import US chipmaking equipment into its China operations.
Shares rose 2.3% to $1,585 on Wednesday.

VS Media Holdings
Announced a 1-for-20 share combination.
Shares jumped 17% to $0.10.

Outlook Therapeutics
Said the FDA issued a complete response letter for the resubmitted biologics license application for ONS-5010 / LYTENAVA, stating it cannot be approved in its current form for treating wet age-related macular degeneration.
Shares plunged 63.3% to $0.58 in after-hours trading.

Rubico Inc
Announced it entered into a purchase agreement to acquire a vessel-owning company tied to a shipbuilding contract for a new mega yacht.
Shares surged 40.2% to $1.50 in after-hours trading.
Transcript
00:00U.S. stock futures are trading higher this Friday morning.
00:03Here are some of the stocks investors are watching today.
00:06Apple has reportedly scaled back production and promotion of its Vision Pro headset
00:10after sluggish sales highlighted challenges in turning the mixed reality device into a mass
00:15market product. Shares fell 0.5% to $271.86 on Wednesday. Taiwan Semiconductor Manufacturing
00:24secured a one-year U.S. export license allowing it to import U.S. chipmaking equipment into its
00:29China operations. Shares rose 2.3% to $1,585 on Wednesday. V.S. Media Holdings announced a
00:371-for-20 share combination. Shares jumped 17% to $0.10 on Wednesday. Outlook Therapeutics said the
00:44FDA issued a complete response letter for the ONS 5010-Liteenava Biologics license application
00:51resubmission, stating the application cannot be approved in its current form for treating wet
00:56age-related macular degeneration. Shares plunged 63.3% to $0.58 in after-hours trading. Rubico
01:04announced it entered into a purchase agreement to acquire a vessel-owning company from top ships,
01:09tied to a shipbuilding contract for a new mega yacht. Shares surged 40.2% to $1.50 in after-hours
01:15trading. Follow Benzinga for more market updates.
Be the first to comment
Add your comment

Recommended